|
|
|
|
Weatherford International plc (NYSE: WFT) today informs its shareholders that it has published its 2014 Annual Report. The digital and interactive report discusses how Weatherford effectively implemented a disciplined strategy to deliver on substantially all of its 2014 objectives, resulting in a keystone year in the Company's turnaround.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7507751-2014-weatherford-annual-report/
Runtime: 2m10s
Views: 972 |
Comments: 0
|
|
|
|
|
Get all the best exclusive Bonnaroo 09 coverage from Fuse Fest all throughout the month of June including the best of this year's festival on June 20th at 8pm|9c only on FUSE! Head to fuse.tv/bonnaroo for updates!
Runtime: 0m36s
Views: 7966 |
Comments: 0
|
|
|
|
|
Robert Johnson Project
From: Keb Mo - Slow down 1998
Runtime: 3m8s
Views: 993 |
Comments: 0
|
|
|
|
|
hotel booking , www.hotelbookingtv.com , hotelbooking, bursa, almira , online hotel booking,
http://www.hotelbookingtv.com
,maxx tatil,www.maxxtatil.com,maxx trip.www.maxxtrip.com,
Runtime: 0m26s
Views: 4791 |
Comments: 0
|
|
|
|
|
A girl who likes makeup
Runtime: 1m34s
Views: 6859 |
Comments: 0
|
|
|
|
|
Breast cancer now represents one in four of all cancers in women worldwide and touches lives every day. While experiences with the disease may vary, the desire to defeat breast cancer is universal. This year, in honor of a shared vision for a world without this disease, The Estée Lauder Companies’ Breast Cancer Awareness (BCA) Campaign celebrates the power of global solidarity by encouraging people around the world to “Take Action Together to Defeat Breast Cancer.” The 2016 BCA Campaign invites women, men and families to draw inspiration from one another and unite in action on BCAcampaign.com and social media, while supporting lifesaving breast cancer research.
Over the past two decades, The Estée Lauder Companies’ BCA Campaign, launched by the late Evelyn H. Lauder, co-creator of the Pink Ribbon and founder of the Breast Cancer Research Foundation® (BCRF), has been a leading voice for breast cancer awareness around the world, igniting a global movement that has helped save millions of lives and fund innovative breast cancer research. Today, The BCA Campaign is active in more than 70 countries and has raised more than $65 million to support global research, education and medical services, with more than $50 million funding 200 BCRF medical research grants worldwide over the past 22 years. These funds help accelerate critical research across wide-ranging areas such as tumor biology, heredity and ethnicity, lifestyle and prevention, treatment, survivorship and metastasis. Around the world, The BCA Campaign partners with more than 60 breast cancer organizations focused on breast cancer research, education and medical services. This year, The BCA Campaign is committed to raising $6 million in support of its mission to defeat breast cancer through education and medical research.
To view the multimedia release go to:
http://www.multivu.com/players/English/7935851-estee-lauder-bca-campaign-2016/
Runtime: 0m30s
Views: 1112 |
Comments: 0
|
|
|
|
|
Read the article related to this video in the Gold City Gazette at Goldcitygazette.zoomvillage.com
Runtime: 0m31s
Views: 895 |
Comments: 0
|
|
|
|
|
[RISA KUMON feat. RORO and TOSHITO TSUSHIMA(Guitar)]
Recorded by Izumi Wada (Sun and Fish Record),
RISA Session Video Episode-1,
Runtime: 4m33s
Views: 3046 |
Comments: 0
|
|
|
|
|
COURTESY of mymockingjay.tumblr.com
Runtime: 0m35s
Views: 8194 |
Comments: 0
|
|
|
|
|
Warren du Preez & Nick Thornton Jones, regarded as two of the creative industry’s leading artists within image-making and film have been asked to live their distinctive approach with Perrier-Jouët.
This collaboration has ended up to a 360° communication where the user is guided to a journey through their vision of Perrier-Jouët’s artistic heritage and unique wine style.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62422-perrier-jouet-global-communications-campaign
Runtime: 0m48s
Views: 2827 |
Comments: 0
|
|
|
|
|
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
Runtime: 2m15s
Views: 8013 |
Comments: 0
|
|
|
|
|
namahang 236
Added: 3991 days ago by
12eza
Runtime: 4m44s
Views: 1147 |
Comments: 0
|
